VolitionRX Limited (NYSEAMERICAN:VNRX - Get Free Report) was down 0.8% during trading on Wednesday . The stock traded as low as $0.69 and last traded at $0.70. Approximately 80,357 shares changed hands during mid-day trading, a decline of 47% from the average daily volume of 152,627 shares. The stock had previously closed at $0.71.
VolitionRX Stock Performance
The stock has a market cap of $66.55 million, a PE ratio of -2.37 and a beta of 1.26. The company has a fifty day moving average of $0.67.
About VolitionRX
(
Get Free Report)
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
Further Reading
Before you consider VolitionRX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VolitionRX wasn't on the list.
While VolitionRX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
